CXCL8 and non-small cell lung carcinoma: A recent study showed that the CD56(+)CD16(−) NK subset in non-small cell lung cancer patients, which represents the predominant NK subset in tumors, was associated with VEGF, placental growth factor (PIGF), and interleukin-8 (IL-8)/CXCL8 production.